AQR Capital Management LLC Has $22.59 Million Stock Position in Doximity, Inc. (NASDAQ:DOCS)

AQR Capital Management LLC raised its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 1,702.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 423,011 shares of the company's stock after buying an additional 399,548 shares during the quarter. AQR Capital Management LLC owned 0.23% of Doximity worth $22,585,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. QSV Equity Investors LLC grew its stake in Doximity by 0.3% during the 4th quarter. QSV Equity Investors LLC now owns 60,763 shares of the company's stock valued at $3,244,000 after acquiring an additional 186 shares in the last quarter. Handelsbanken Fonder AB boosted its holdings in shares of Doximity by 0.7% during the fourth quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company's stock worth $1,586,000 after purchasing an additional 200 shares during the period. UMB Bank n.a. grew its position in Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after purchasing an additional 235 shares in the last quarter. Fielder Capital Group LLC increased its stake in Doximity by 4.5% in the 4th quarter. Fielder Capital Group LLC now owns 5,488 shares of the company's stock valued at $293,000 after buying an additional 235 shares during the period. Finally, Larson Financial Group LLC lifted its position in Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after buying an additional 250 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Doximity

In other Doximity news, CFO Anna Bryson sold 45,000 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total value of $2,575,350.00. Following the completion of the sale, the chief financial officer now owns 357,165 shares in the company, valued at approximately $20,440,552.95. This trade represents a 11.19 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the sale, the director now directly owns 16,618 shares in the company, valued at $946,062.74. This trade represents a 10.74 % decrease in their position. The disclosure for this sale can be found here. 37.40% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

DOCS has been the topic of a number of research reports. Piper Sandler raised shares of Doximity from a "neutral" rating to an "overweight" rating and upped their price target for the stock from $31.00 to $78.00 in a research note on Friday, February 7th. Raymond James reiterated an "outperform" rating and issued a $83.00 target price (up from $65.00) on shares of Doximity in a research note on Friday, February 7th. Leerink Partnrs upgraded shares of Doximity from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 7th. Wells Fargo & Company reaffirmed an "equal weight" rating on shares of Doximity in a research note on Friday, February 7th. Finally, Leerink Partners raised shares of Doximity from a "market perform" rating to an "outperform" rating and increased their target price for the stock from $60.00 to $90.00 in a research report on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, Doximity currently has a consensus rating of "Moderate Buy" and an average price target of $65.39.

Doximity Stock Up 1.9 %

Doximity stock traded up $1.09 during mid-day trading on Wednesday, reaching $58.19. The company had a trading volume of 2,083,716 shares, compared to its average volume of 2,006,108. The company has a 50 day moving average of $58.58 and a 200-day moving average of $56.90. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21. The firm has a market cap of $10.86 billion, a price-to-earnings ratio of 58.19, a PEG ratio of 4.10 and a beta of 1.41.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.